Evaluation of antidiabetic and antioxidant potential of lupeol in experimental hyperglycaemia

Nat Prod Res. 2012;26(12):1125-9. doi: 10.1080/14786419.2011.560845. Epub 2011 Nov 1.

Abstract

Oxidative stress, produced under diabetic conditions, is a possible cause of various forms of tissue damage. The concentrations of antioxidant enzymes in cases of diabetes are significantly decreased, with a concomitant increase in lipid peroxidation. In this study, lupeol, a phytoconstituent from Solanum xanthocarpum, is shown to suppress the progression of diabetes after 21 days. Lupeol treatment caused decreases in glycated haemoglobin, serum glucose and nitric oxide, with a concomitant increase in serum insulin level. Furthermore, treatment with lupeol also increased antioxidant levels, with a decrease in the level of thiobarbituric acid-reactive oxygen species.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Blood Glucose / analysis
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / drug therapy
  • Drug Evaluation, Preclinical
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Pentacyclic Triterpenes / pharmacology
  • Pentacyclic Triterpenes / therapeutic use*
  • Rats

Substances

  • Antioxidants
  • Blood Glucose
  • Hypoglycemic Agents
  • Pentacyclic Triterpenes
  • lupeol